Claire Riley

2.6k total citations
67 papers, 1.2k citations indexed

About

Claire Riley is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Claire Riley has authored 67 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pathology and Forensic Medicine, 14 papers in Neurology and 9 papers in Oncology. Recurrent topics in Claire Riley's work include Multiple Sclerosis Research Studies (43 papers), Polyomavirus and related diseases (7 papers) and Long-Term Effects of COVID-19 (6 papers). Claire Riley is often cited by papers focused on Multiple Sclerosis Research Studies (43 papers), Polyomavirus and related diseases (7 papers) and Long-Term Effects of COVID-19 (6 papers). Claire Riley collaborates with scholars based in United States, Italy and Slovakia. Claire Riley's co-authors include Victoria M. Leavitt, Shyam Prabhakaran, Ji Y. Chong, Ronald M. Lazar, John W. Krakauer, Randolph S. Marshall, Eric Zarahn, Philip L. De Jager, Fred Lublin and Aaron Miller and has published in prestigious journals such as PLoS ONE, Neurology and BMJ Open.

In The Last Decade

Claire Riley

64 papers receiving 1.2k citations

Peers

Claire Riley

PFM

REHAB

NEURO

EPIDE

Katharina Feil Germany

Bahia Hakiki Italy

Giancarlo Coghe Italy

Juhani Ruutiainen Finland

Egemen İdıman Türkiye

Melanie Adams United States

Serkan Özakbaş Türkiye

Liesly Lee Canada

Giovanna Borriello Italy

Alan Bryer South Africa

Katharina Feil Germany

Claire Riley

263 ×0.5

PFM

88 ×0.3

REHAB

415 ×1.3

NEURO

403 ×2.1

NEURO

294 ×1.8

EPIDE

Citations per year, relative to Claire Riley Claire Riley (= 1×) peers Katharina Feil

Countries citing papers authored by Claire Riley

Since Specialization

Citations

This map shows the geographic impact of Claire Riley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Riley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Riley more than expected).

Fields of papers citing papers by Claire Riley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Riley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Riley. The network helps show where Claire Riley may publish in the future.

Co-authorship network of co-authors of Claire Riley

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Riley. A scholar is included among the top collaborators of Claire Riley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Riley. Claire Riley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Farber, Rebecca Straus, Fatoumata Diallo, Claire Riley, et al.. (2024). A randomized cross-over trial of prebiotics and probiotics in multiple sclerosis: Trial feasibility, supplement tolerability and symptom abatement. Multiple Sclerosis and Related Disorders. 89. 105762–105762. 5 indexed citations

Riley, Claire, Amar Dhand, Katelyn Kavak, et al.. (2023). Impact of the COVID-19 Pandemic on the Personal Networks and Neurological Outcomes of People With Multiple Sclerosis: Cross-Sectional and Longitudinal Case-Control Study. JMIR Public Health and Surveillance. 10. e45429–e45429. 2 indexed citations

Riley, Claire, et al.. (2022). Diagnosis concealment is associated with psychosocial outcomes in persons with multiple sclerosis. Multiple Sclerosis Journal. 28(8). 1311–1314. 5 indexed citations

Buyukturkoglu, Korhan, Jordan D. Dworkin, Frank A. Provenzano, et al.. (2022). Brain volumetric correlates of remotely versus in-person administered symbol digit modalities test in multiple sclerosis. Multiple Sclerosis and Related Disorders. 68. 104247–104247. 2 indexed citations

Jakimovski, Dejan, Katelyn Kavak, Erin E. Longbrake, et al.. (2022). Impact of resilience, social support, and personality traits in patients with neuroinflammatory diseases during the COVID-19 pandemic. Multiple Sclerosis and Related Disorders. 68. 104235–104235. 8 indexed citations

Cohen, Inessa, Keith R. Edwards, Bianca Weinstock‐Guttman, et al.. (2022). Worsening physical functioning in patients with neuroinflammatory disease during the COVID-19 pandemic. Multiple Sclerosis and Related Disorders. 58. 103482–103482. 8 indexed citations

Thakkar, Riddhi, James Ng, David Bearden, et al.. (2022). Compassionate-use pocapavir and immunoglobulin therapy for treatment of rituximab-associated enterovirus meningoencephalitis. Journal of NeuroVirology. 28(2). 329–334. 7 indexed citations

Langston, Christopher, Anusha K. Yeshokumar, Michelle Fabian, et al.. (2021). Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: The difficulty of predicting relapses. Multiple Sclerosis and Related Disorders. 56. 103229–103229. 22 indexed citations

Jager, Philip L. De, et al.. (2021). Evaluation of ocrelizumab in older progressive multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 55. 103171–103171. 6 indexed citations

10.

Brandstadter, Rachel, Stephen Krieger, Noam Y. Harel, et al.. (2020). Detection of subtle gait disturbance and future fall risk in early multiple sclerosis. Neurology. 94(13). e1395–e1406. 35 indexed citations

11.

Nelson, Katherine, et al.. (2020). ASPIRE trial: study protocol for a double-blind randomised controlled trial of aspirin for overheating during exercise in multiple sclerosis. BMJ Open. 10(11). e039691–e039691. 2 indexed citations

12.

Buyukturkoglu, Korhan, Enricomaria Mormina, Philip L. De Jager, Claire Riley, & Victoria M. Leavitt. (2019). The Impact of MRI T1 Hypointense Brain Lesions on Cerebral Deep Gray Matter Volume Measures in Multiple Sclerosis. Journal of Neuroimaging. 29(4). 458–462. 2 indexed citations

13.

Krysko, Kristen M., Sara C. LaHue, Annika Anderson, et al.. (2019). Minimal breast milk transfer of rituximab, a monoclonal antibody used in neurological conditions. Neurology Neuroimmunology & Neuroinflammation. 7(1). 38 indexed citations

14.

Leavitt, Victoria M., et al.. (2019). Cognitive Signatures of Depression and Anxiety in Multiple Sclerosis (S6.008). Neurology. 92(15_supplement). 1 indexed citations

15.

Diaconu, Claudiu, et al.. (2019). Central Meningioma Necrosis after CAR T-Cell Therapy (P2.6-001). Neurology. 92(15_supplement). 1 indexed citations

16.

Leavitt, Victoria M., et al.. (2018). Cognitive phenotypes in multiple sclerosis. Journal of Neurology. 265(3). 562–566. 54 indexed citations

17.

Riley, Claire, et al.. (2017). A 31-Year-Old Man With a Ring-Enhancing Brain Lesion. Journal of Neuro-Ophthalmology. 37(2). 172–175.

18.

Leavitt, Victoria M., et al.. (2016). Elevated Brain Temperature Is Associated with Worse Fatigue in Relapsing Remitting Multiple Sclerosis Patients (P2.172). Neurology. 86(16_supplement). 1 indexed citations

19.

Noriega, Mercedes, Cristina Soler, Ignacio Bonelli, et al.. (2011). Acute Demyelinating Disease after Oral Therapy with Herbal Extracts. Case Reports in Neurology. 3(2). 141–146. 2 indexed citations

20.

Riley, Claire. (1999). Evidential understanding, period knowledge and the development of literacy: A practical approach. Teaching history. 6–12. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact